Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SAPIEN 3 Ultra System PMCF

NCT: NCT04555967 · ACTIVE_NOT_RECRUITING

NCT IDNCT04555967
StatusACTIVE_NOT_RECRUITING
Start Date2020-06-30
Completion2026-11

Brief Summary

A post-market study of the Edwards SAPIEN 3 Ultra System in subjects with symptomatic, severe, calcific aortic stenosis.

Frequently Asked Questions

What is SAPIEN 3 Ultra System PMCF?

SAPIEN 3 Ultra System PMCF is a clinical trial registered under NCT04555967. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04555967?

The current status of NCT04555967 (SAPIEN 3 Ultra System PMCF) is: ACTIVE_NOT_RECRUITING.

When did SAPIEN 3 Ultra System PMCF start?

SAPIEN 3 Ultra System PMCF started on 2020-06-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.